The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+channel,IKCa1: A potential immunosuppressant
Open accessAbstract
The antimycotic clotrimazole, a potent inhibitor of the intermediate-conductance calcium-activated K+channel,IKCa1, is in clinical trials for the treatment of sickle cell disease and diarrhea and is effective in ameliorating the symptoms of rheumatoid arthritis. However, inhibition of cytochrome P450 enzymes by clotrimazole limits its therapeutic value. We have used a rational design strategy to develop a clotrimazole analog that selectively inhibits IKCa1 without blocking cytochrome P450 enzymes. A screen of 83 triarylmethanes revealed the pharmacophore for channel block to be different from that required for cytochrome P450 inhibition. The “IKCa1-pharmacophore” consists of a (2-halogenophenyl)diphenylmethane moiety substituted by an unsubstituted polar π-electron-rich heterocycle (pyrazole or tetrazole) or a −C 000000000000 000000000000 111111111111 000000000000 111111111111 000000000000 111111111111 000000000000 000000000000 N group, whereas cytochrome P450 inhibition absolutely requires the imidazole ring. A series of pyrazoles, acetonitriles, and tetrazoles were synthesized and found to selectively block IKCa1. TRAM-34 (1-[(2-chlorophenyl)diphenylmethyl]-1 H-pyrazole) inhibits the cloned and the native IKCa1 channel in human T lymphocytes with a Kd of 20–25 nM and is 200- to 1,500-fold selective over other ion channels. Using TRAM-34, we show that blocking IKCa1 in human lymphocytes, in the absence of P450-inhibition, results in suppression of mitogen-stimulated [3 H]thymidine incorporation of preactivated lymphocytes with EC 50-values of 100 nM-1 μM depending on the donor. Combinations of TRAM-34 and cyclosporin A are more effective in suppressing lymphocyte mitogenesis than either compound alone. Our studies suggest that TRAM-34 and related compounds may hold therapeutic promise as immunosuppressants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Structure of the Potassium Channel: Molecular Basis of K + Conduction and Selectivity
Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., & MacKinnon, R. (1998) · Science · doi:10.1126/science.280.5360.69 · Cited by 6,807
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Hastings, R. C., & Long, G. W. (1991) · JAMA · doi:10.1001/jama.1991.03460200114048 · Cited by 1,060
Grissmer, S., Nguyen, A. N., Aiyar, J., Hanson, D. C., Mather, R. J., Gutman, G. A., Karmilowicz, M. J., Auperin, D. D., & Chandy, K. G. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10594-4 · Cited by 777
Self-citationA human intermediate conductance calcium-activated potassium channel
Ishii, T. M., Silvia, C., Hirschberg, B., Bond, C. T., Adelman, J. P., & Maylie, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11651 · Cited by 612
hSK4, a member of a novel subfamily of calcium-activated potassium channels
Joiner, W. J., Wang, L.-Y., Tang, M. D., & Kaczmarek, L. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.11013 · Cited by 380
Calmodulin Mediates Calcium-dependent Activation of the Intermediate Conductance KCa Channel,IKCa1
Fanger, C. M., Ghanshani, S., Logsdon, N. J., Rauer, H., Kalman, K., Zhou, J., Beckingham, K., Chandy, K. G., Cahalan, M. D., & Aiyar, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5746 · Cited by 328
Self-citationEconazole: A Review of its Antifungal Activity and Therapeutic Efficacy
Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1978) · Drugs · doi:10.2165/00003495-197816030-00001 · Cited by 296
A Novel Gene, hKCa4, Encodes the Calcium-activated Potassium Channel in Human T Lymphocytes
Logsdon, N. J., Kang, J., Togo, J. A., Christian, E. P., & Aiyar, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.32723 · Cited by 285
High affinity inhibition of Ca(2+)-dependent K+ channels by cytochrome P-450 inhibitors.
Alvarez, J., Montero, M., & Garcia-Sancho, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49767-6 · Cited by 281
Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity
Henderson, G. L., Harkey, M. R., Gershwin, M. E., Hackman, R. M., Stern, J. S., & Stresser, D. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00407-5 · Cited by 274
Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture
Maurice, M., Pichard, L., Daujat, M., Fabre, I., Joyeux, H., Domergue, J., & Maurel, P. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.2.1371482 · Cited by 262
ShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide
Kalman, K., Pennington, M. W., Lanigan, M. D., Nguyen, A., Rauer, H., Mahnir, V., Paschetto, K., Kem, W. R., Grissmer, S., Gutman, G. A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32697 · Cited by 256
Self-citationBrugnara, C., Gee, B., Armsby, C. C., Kurth, S., Sakamoto, M., Rifai, N., Alper, S. L., & Platt, O. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118537 · Cited by 235
Grissmer, S., Nguyen, A. N., & Cahalan, M. D. (1993) · The Journal of general physiology · doi:10.1085/jgp.102.4.601 · Cited by 229
Self-citationhSK4/hIK1, a Calmodulin-binding KCa Channel in Human T Lymphocytes
Khanna, R., Chang, M. C., Joiner, W. J., Kaczmarek, L. K., & Schlichter, L. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14838 · Cited by 217
cDNA Cloning and Functional Characterization of the Mouse Ca2+-gated K+ Channel, mIK1
Vandorpe, D. H., Shmukler, B. E., Jiang, L., Lim, B., Maylie, J., Adelman, J. P., de Franceschi, L., Cappellini, M. D., Brugnara, C., & Alper, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21542 · Cited by 198
Ion channels in the immune system as targets for immunosuppression
Cahalan, M. D., & Chandy, K. G. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80130-9 · Cited by 148
Self-citationSingle-Channel Recording of a Store-Operated Ca 2+ Channel in Jurkat T Lymphocytes
Kerschbaum, H. H., & Cahalan, M. D. (1999) · Science · doi:10.1126/science.283.5403.836 · Cited by 134
Self-citationSawyer, P. R., Brogden, R. N., Pinder, R. M., Speight, T. M., & Avery, G. S. (1975) · Drugs · doi:10.2165/00003495-197509060-00003 · Cited by 134
Rauer, H., Pennington, M. W., Cahalan, M. D., & Chandy, K. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21885 · Cited by 133
Self-citationInteractions of imidazole antifungal agents with purified cytochrome P-450 proteins
Rodrigues, A. D., Gibson, G. G., Ioannides, C., & Parke, D. V. W. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90670-8 · Cited by 120
Rufo, P. A., Merlin, D., Riegler, M. F., Ferguson-Maltzman, M., Dickinson, B. L., Brugnara, C., Alper, S. L., & Lencer, W. I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119866 · Cited by 116
Inhibition of T cell proliferation by selective block of Ca 2+ -activated K + channels
Jensen, B., Ødum, N., Jørgensen, N. K., Christophersen, P., & Olesen, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10917 · Cited by 115
Hess, S. D., Oortgiesen, M., & Cahalan, M. D. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.7.2620 · Cited by 109
Self-citationMembrane chloride conductance and capacitance in Jurkat T lymphocytes during osmotic swelling
Ross, P. E., Garber, S. S., & Cahalan, M. D. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80754-4 · Cited by 91
Self-citationGibbs, M. A., Kunze, K. L., Howald, W. N., & Thummel, K. E. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15255-5 · Cited by 59
Verheugen, J. A. H., Deist, F. L., Devignot, V., & Korn, H. (1997) · Cell Calcium · doi:10.1016/s0143-4160(97)90092-0 · Cited by 53
Dunn, P. M. (1998) · The Journal of Membrane Biology · doi:10.1007/s002329900427 · Cited by 50
Jäger, H., Adelman, J. P., & Grissmer, S. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01236-9 · Cited by 49
Self-citationClotrimazole in rheumatoid arthritis.
Wojtulewski, J. A., Gow, P. J., Walter, J., Grahame, R., Gibson, T., Panayi, G. S., & Mason, J. (1980) · Annals of the Rheumatic Diseases · doi:10.1136/ard.39.5.469 · Cited by 41
Ayub, M., & LEVELL, M. J. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90456-u · Cited by 25
[Synthesis and properties of clotrimazole and other antimycotic 1-triphenylmethylimidazoles].
Büchel, K. H., Draber, W., Regel, E., & Plempel, M. (1972) · PubMed · Cited by 16
Cited by
Wei, A. D., Gutman, G. A., Aldrich, R., Chandy, K. G., Grissmer, S., & Wulff, H. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.9 · Cited by 978
Self-citationCalcium signaling mechanisms in T lymphocytes.
Lewis, R. S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.497 · Cited by 860
Piezo1 links mechanical forces to red blood cell volume
Cahalan, S. M., Lukacs, V., Ranade, S. S., Chien, S., Bandell, M., & Patapoutian, A. (2015) · eLife · doi:10.7554/elife.07370 · Cited by 624
The functional network of ion channels in T lymphocytes
Cahalan, M. D., & Chandy, K. G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00816.x · Cited by 599
Self-citationPotassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Shieh, C.-C., Coghlan, M., Sullivan, J. P., & Gopalakrishnan, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01469-8 · Cited by 518
Metadata
- Authors
- Wulff, H., Miller, M. J., Hänsel, W., Grissmer, S., Cahalan, M. D., & Chandy, K. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-07-05
- Volume
- 97
- Issue
- 14
- Pages
- 8151-8156
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2161387630
- Cited by
- 604
- References
- 32
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.